Cannabis sales revenue in France
A new direct estimate by expenditure
Tendances n° 137, OFDT, 6 p.
Estimating the amount of cannabis sales revenue is important and provides a measure of the influence of this economic sector. However, this exercise faces two major obstacles, since both the quantities sold and the retail prices of an illicit product remain, by definition, unknown in public statistics.
In order to get around these difficulties, the OFDT has introduced in 2017 a specific module in two general population surveys (Health Barometer and ESCAPAD) which directly questions users on the frequency of their cannabis purchases during the year and the amount of their last expenditure. If the primary objective is to renew the estimate, it is also a question of testing a calculation method that is easily reproducible and comparable over time.
This issue of Tendances, which was first published in French in March, reports on the use of these new questions asked simultaneously in these two surveys and proposes a new estimate of the cannabis market in France’s sales revenue which reached 1.2 billion euros (1.3 billion $) in 2017. The relative simplicity of this method should facilitate the integration of the questions into other surveys, particularly those conducted in other European countries, and thus make international comparisons more reliable.
Authors : Stanislas Spilka (OFDT), Stéphane Legleye (INSEE)
Download the PDF file (426 Ko)
Drugs in Europe
What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2019 EMCDDA European Drug Report.
Country drug reports 2019
Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.